Evidence map›Paper›PMID 26126692›Full record

ArticleUrology2015

Collagenase Clostridium histolyticum (Xiaflex) for the Treatment of Urethral Stricture Disease in a Rat Model of Urethral Fibrosis.

Premsant Sangkum, Faysal A Yafi, Hogyoung Kim, Mostafa Bouljihad, Manish Ranjan, Amrita Datta, Sree Harsha Mandava, Suresh C Sikka, Asim B Abdel-Mageed, Krishnarao Moparty and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in Urology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02948842 (Clostridium Histolyticum Collagenase Injection Treatment for Urethral Disease), which is not on this map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02948842 phase2completednot on this mapstarted 2020, after this paper: background citation

Clostridium Histolyticum Collagenase Injection Treatment for Urethral Disease: a Prospective, Single-center, Open-label Study

TypeinterventionalSponsorUniversity of South FloridaRan2020 to 2023Enrolled5ConditionsUrethral StrictureArmsClostridium Histolyticum Collagenase, Saline
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. CollagenasePatient preference and adherence · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Premsant SangkumDepartment of Urology, Tulane University School of Medicine, New Orleans, LA.
Faysal A YafiDepartment of Urology, Tulane University School of Medicine, New Orleans, LA.
Hogyoung KimDepartment of Urology, Tulane University School of Medicine, New Orleans, LA.
Mostafa BouljihadDivision of Comparative Pathology, Tulane National Primate Research Center, Covington, LA.
Manish RanjanDepartment of Urology, Tulane University School of Medicine, New Orleans, LA.
Amrita DattaDepartment of Urology, Tulane University School of Medicine, New Orleans, LA.
Sree Harsha MandavaDepartment of Urology, Tulane University School of Medicine, New Orleans, LA.
Suresh C SikkaDepartment of Urology, Tulane University School of Medicine, New Orleans, LA.
Asim B Abdel-MageedDepartment of Urology, Tulane University School of Medicine, New Orleans, LA.
Krishnarao MopartyDepartment of Urology, Tulane University School of Medicine, New Orleans, LA.
Wayne J G HellstromDepartment of Urology, Tulane University School of Medicine, New Orleans, LA. Electronic address: whellst@tulane.edu.
Tulane University · US

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
NIH HHS P51 OD011104PHS HHS P510D011104
6 · The paper itself

Abstract

objectiveTo evaluate the treatment effect of collagenase Clostridium histolyticum (CCH) in a rat model of urethral fibrosis. MATERIALS AND

methodsThirty male Sprague-Dawley rats (300-350 g) were divided into 5 groups. The rat urethra was injected with normal saline in the sham group and, in the other 4 groups, the rat urethra was injected with 10 μg of transforming growth factor beta 1 to create fibrosis of the urethra. Two weeks following transforming growth factor beta 1 injection, the rats were injected with varying doses of CCH or vehicles, depending on their group. The rats were then euthanized at 4 weeks after CCH or vehicle injection. Urethral tissue was harvested for histologic and molecular analyses. Type I and III collagen levels were evaluated by Western blot analysis.

resultsThere was urethral fibrosis and to significant increase in collagen type I and III expressions in the urethral fibrosis group compared with the sham group (P <.05). Urethral injection of CCH appeared to be safe and significantly reduce urethral fibrosis as well as collagen type I and III expressions in the high-dose CCH treatment groups when compared with the treatment control group (P <.01).

conclusionThis study demonstrated a beneficial effect of CCH injections in a rat model of urethral fibrosis. These findings suggest a potential role for CCH as a therapeutic option in urethral stricture patients and warrant further investigation.

Indexed as

AnimalsDisease Models, AnimalFibrosisMaleMicrobial CollagenaseRatsRats, Sprague-DawleyUrethraUrethral StrictureMicrobial Collagenase

Identifiers

PMID26126692
PMCPMC4914046
OpenAlexW2105742025

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.